Latest Corporate News News
ProstACT Global Phase 3 Trial Selected as Late-Breaking Abstract at ASCO 2026
ProstACT Global Phase 3 (Part 1) has been chosen as a late-breaking abstract for presentation at ASCO 2026. This milestone highlights promising interim results from the prostate cancer therapy trial. The announcement was made via GlobeNewswire press release.
Wall Street Closes Lower as Middle East Concerns Offset Earnings Optimism
US stocks fell on April 21, with the S&P 500 reversing early gains due to escalating Middle East war fears. Solid corporate earnings and AI optimism provided some uplift, but could not counter geopolitical risks. Retail sales surged 1.7% in March amid higher gasoline prices.
UnitedHealth Raises Annual Profit Forecast After Strong Q1 Earnings
UnitedHealth shares jumped 7% after exceeding Wall Street Q1 expectations and lifting its full-year profit outlook. The healthcare giant was the top Dow booster, adding about 138 points. This reflects robust performance in a volatile market.